JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the issuance of Auto Callable Contingent Interest Notes linked to the MerQube US Large-Cap Vol Advantage Index, with a maturity date of July 24, 2029. The notes, which are designed for investors seeking monthly Contingent Interest Payments when the Index closes at or above 70% of its Initial Value, will be automatically called if the Index's closing level on any quarterly Autocall Review Date is at or above the Initial Value. The first possible automatic call date is January 21, 2025. The notes carry the risk of losing principal and the possibility of receiving no Contingent Interest Payments. The Index includes a 6.0% per annum daily deduction, which will...Show More

JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the issuance of Auto Callable Contingent Interest Notes linked to the MerQube US Large-Cap Vol Advantage Index, with a maturity date of July 24, 2029. The notes, which are designed for investors seeking monthly Contingent Interest Payments when the Index closes at or above 70% of its Initial Value, will be automatically called if the Index's closing level on any quarterly Autocall Review Date is at or above the Initial Value. The first possible automatic call date is January 21, 2025. The notes carry the risk of losing principal and the possibility of receiving no Contingent Interest Payments. The Index includes a 6.0% per annum daily deduction, which will affect its performance. The notes are unsecured and unsubordinated obligations of JPMorgan Financial, guaranteed by JPMorgan Chase & Co., and subject to their credit risks. The notes are expected to price on or about July 19, 2024, and to settle on or about July 24, 2024. Investing in the notes involves a number of risks, detailed in the accompanying prospectus supplement and other offering documents. The Securities and Exchange Commission has not approved or disapproved the notes, nor have they passed upon the accuracy or adequacy of the pricing supplement or the accompanying documents.